Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Manny Gugliuzza who wrote (258)	2/27/1998 2:25:00 PM
From: Robert DeHaven	Read Replies (1) \| Respond to of 1510

Manny: All I can say is from everyone I know who has purchased IMNR and is long IMNR they know of no fundamental change in this company. As a matter of fact they believe that we are now at the very beginning of what should be a very good period for the stock. 1. Results from all Remune trials continue to come out positive 2. Recent earnings release states that "Corporate collaberation" on products is being pursued.... 3. The pipeline gets closer and closer to actual revenue generating products every day. There was a time in APCO when everyone questioned its future because of a weak stock price...now its 50% higher....IMHO thats going to be the case in IMNR. Just wait....good news is coming. good luck, bob